ABSTRACT
Operation Outbreak (OO), an app-based, educational outbreak simulator, seeks to engage, educate, and empower citizens to prevent and better respond to infectious disease outbreaks. We examine the utility of OO for further understanding and mitigating the spread of communicable diseases. The OO smartphone app uses Bluetooth to spread a virtual pathogen among nearby participants’ devices to simulate an outbreak, providing an experiential learning opportunity. Deployed at many college campuses and other settings, the app collects these anonymized spatio-temporal data, including the time and duration of the contacts among participants of the simulation. Here, we report the distribution, timing, duration, and connectedness of student social contacts at two university deployments and uncover cryptic transmission pathways through individuals’ second-degree contacts. We then construct epidemiological models based on the contact networks generated by OO to predict the transmission pathways of hypothetical pathogens with varying reproductive numbers. Finally, we show that the granularity of OO data enables institutions to improve outbreak mitigation by proactively and strategically testing and/or vaccinating individuals based on individual social interaction levels.
BIGGER PICTURE Outbreak simulation technology can greatly enhance individual and community pandemic preparedness while also helping us understand and mitigate outbreak spread. Building on an existing platform called Operation Outbreak (OO)––an app-based program that spreads a virtual pathogen via Bluetooth among participants’ smartphones––we demonstrate the power of this approach. We investigate the first- and second-degree contacts of OO participants, analyzing the differential risk associated with various local contact network structures. We use OO data to construct an epidemiological model, with which communities may predict the spread of infectious agents and assess the effectiveness of mitigation measures. Based on our findings, we advocate for the wider adoption of outbreak simulation technology to study the implications of social mixing patterns on outbreaks within close-knit communities, to aid pandemic preparedness and response.
Competing Interest Statement
PCS is a co-founder and shareholder of Sherlock Biosciences and is a non-executive board member and shareholder of Danaher Corporation. AC, TB, and PCS are inventors on patents related to diagnostics and Bluetooth-based contact tracing tools and technologies filed with the USPTO and other intellectual property bodies. All other authors declare no competing interests.
Funding Statement
This work was made possible by the Gordon and Betty Moore Foundation grant numbers #9125 and #9125.01.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Brigham Young University Institutional Review Board determined this work to be non-human subjects research (Protocol IRB2021-207). Harvard Longwood Campus Institutional Review Board of Harvard University determined this work to be non-human subjects research (as is typical for non-human subjects research projects at Harvard, no protocol number was issued). The University of Massachusetts Chan Medical School Institutional Review Board determined this work to be non-human subjects research (Protocol H00024280). The Colorado Mesa University Institutional Review Board determined this work to be non-human subjects research (Protocol 21-44). Lastly, The Broad Institute of MIT and Harvard's Office of Research Subject Protections determined this work to be exempt (Protocol EX-6991).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All code and data necessary to run the model and generate the figures is available at https://github.com/broadinstitute/OO-modeling.
